Rebecca Abraham

Murdoch University

Papers

3

Total Citations

32

H-Index

3

About

Rebecca Abraham is an innovative researcher at the forefront of antimicrobial resistance (AMR) surveillance, with a focus on developing scalable, high-throughput technologies to address one of global public health's most pressing challenges. Her most celebrated contribution is the development of the Robotic Antimicrobial Susceptibility Platform (RASP), a groundbreaking automation-driven system designed to overcome the critical scalability limitations that have long constrained traditional AMR monitoring. This work, published in 2021 and garnering nearly 30 citations across related publications, represents a significant leap forward in One Health surveillance — an integrated approach recognizing the interconnectedness of human, animal, and environmental health. Building on this foundation, Abraham extended her research to demonstrate RASP's real-world impact in food safety, using augmented surveillance to detect the transnational spread of fluoroquinolone-resistant *Escherichia coli* strains into poultry populations — a finding with direct implications for public health risk assessment. Her work highlights the dangerous inadequacy of current national sampling programs and advocates for affordable, large-scale alternatives. Through her pioneering integration of robotics and epidemiology, Abraham is reshaping how scientists detect and respond to emerging resistance threats across species and borders.

Research Focus

Key Achievements

3
H-Index
3
Papers
32
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance
24 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Murdoch University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago